Mylan gets US FDA nod for generic version of Parkinson's treatment Sinemet
Saturday, October 03, 2009 13:00 IST Pittsburgh
Mylan Inc announced that its subsidiary Mylan Pharmaceuticals Inc has received approval from the US Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Carbidopa and Levodopa tablets USP